立即開始
TradeWithTyler

CLRB Phase 1 Success

Cellectar Biosciences, Inc. (NASDAQ:CLRB)  
TradeWithTyler  
NASDAQ:CLRB   Cellectar Biosciences, Inc.
Trend Analysis Chart Patterns Technical Indicators CLRB Stocks
1
0
trendanalysis chartpattern indicator clrb stocks
Positive news today "CLR 131 Achieves 50% Overall Response Rate in Cohort 6 of Ongoing Phase 1 Study in Relapsed or Refractory Multiple Myeloma". This stock Shs Float is 5.15M, and Market Cap 14.76M.
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。